BridgeBio Pharma, Inc. (BBIO) News & Info.

#ThinkSabio Latest News

BridgeBio Announces Infigratinib Is the First Ever Investigational Therapeutic Option for Achondroplasia to Be Awarded Breakthrough Therapy Designation by the FDA